Pharmacokinetic, Safety and Tolerability Study of SPARC1028

NCT01305512 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor in Advanced Stage

Interventions

DRUG: SPARC1028

Sponsor

Sun Pharma Advanced Research Company Limited